Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ImmunoPrecise Antibodies Ltd. IPA

Set alert

Price alert · IPA

All alert types
1.62 0.00 0.00%

As of Oct 20, 2:54 PM ET

1.56 Day range 1.65
0.325 52-week range 2.60
Open
1.65
Prev close
1.62
Mkt cap
12.39M
Vol
55.66K
Avg vol
558.86K
EPS
-0.75
P/E
0.00
Div yield
0.00%
More statistics
Low
1.56
High
1.65
Forward P/E
-2.49
Beta
0.27
Short ratio
0.70
Inst. own
6.58%
Dividend
0.00
Ex-div date
Earnings
Sep 16, 2024
50-d avg
0.452
200-d avg
0.882795
1y target
5.00

6M chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The six-month price history for IPA has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-1.07 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -7.0×
FY 2016: 55.0×FY 2017: -4.2×FY 2018: -8.4×FY 2019: -6.5×FY 2020: -10.8×FY 2021: -26.6×FY 2022: -8.4×FY 2023: -5.9×FY 2024: -6.0×FY 2025: -7.0×
FY 2016 5y median -7.0× FY 2025
P/S 8.7×
FY 2016: 5.8×FY 2017: 8.7×FY 2018: 8.0×FY 2019: 4.6×FY 2020: 3.8×FY 2021: 11.0×FY 2022: 7.3×FY 2023: 7.5×FY 2024: 6.7×FY 2025: 8.7×
FY 2016 5y median 7.5× FY 2025
P/B 9.0×
FY 2016: 12.1×FY 2017: 7.4×FY 2018: 3.4×FY 2019: 2.8×FY 2020: 3.5×FY 2021: 3.5×FY 2022: 1.9×FY 2023: 2.7×FY 2024: 4.8×FY 2025: 9.0×
FY 2016 5y median 3.5× FY 2025
P/FCF -29.5×
FY 2016: 41.2×FY 2017: -18.2×FY 2018: -11.6×FY 2019: -12.9×FY 2020: -26.9×FY 2021: -97.4×FY 2022: -12.6×FY 2023: -7.3×FY 2024: -28.9×FY 2025: -29.5×
FY 2016 5y median -28.9× FY 2025
EV/EBITDA -7.5×
FY 2016: 36.2×FY 2017: -3.7×FY 2018: -10.5×FY 2019: -11.7×FY 2020: -122×FY 2021: -112×FY 2022: -9.5×FY 2023: -7.4×FY 2024: -7.6×FY 2025: -7.5×
FY 2016 5y median -7.6× FY 2025
EV/Sales 8.8×
FY 2016: 5.6×FY 2017: 7.7×FY 2018: 8.4×FY 2019: 4.3×FY 2020: 3.9×FY 2021: 8.9×FY 2022: 5.9×FY 2023: 7.5×FY 2024: 7.1×FY 2025: 8.8×
FY 2016 5y median 7.5× FY 2025
FCF Yield -3.4%
FY 2016: 2.4%FY 2017: -5.5%FY 2018: -8.6%FY 2019: -7.7%FY 2020: -3.7%FY 2021: -1.0%FY 2022: -7.9%FY 2023: -13.7%FY 2024: -3.5%FY 2025: -3.4%
FY 2016 5y median -3.5% FY 2025

Profitability

Gross Margin 55.3%
FY 2016: 84.3%FY 2017: 54.0%FY 2018: 45.0%FY 2019: 48.5%FY 2020: 57.1%FY 2021: 64.4%FY 2022: 56.7%FY 2023: 56.0%FY 2024: 49.2%FY 2025: 55.3%
FY 2016 5y median 56.0% FY 2025
Operating Margin -49.7%
FY 2016: 12.8%FY 2017: -52.7%FY 2018: -83.5%FY 2019: -59.7%FY 2020: -29.1%FY 2021: -23.3%FY 2022: -79.8%FY 2023: -123.9%FY 2024: -56.1%FY 2025: -49.7%
FY 2016 5y median -56.1% FY 2025
Net Margin -123.3%
FY 2016: 8.0%FY 2017: -204.6%FY 2018: -95.0%FY 2019: -69.7%FY 2020: -35.2%FY 2021: -41.0%FY 2022: -86.3%FY 2023: -128.5%FY 2024: -110.8%FY 2025: -123.3%
FY 2016 5y median -110.8% FY 2025
ROE -128.0%
FY 2016: 16.6%FY 2017: -174.1%FY 2018: -40.7%FY 2019: -42.2%FY 2020: -32.8%FY 2021: -12.9%FY 2022: -22.2%FY 2023: -45.9%FY 2024: -80.1%FY 2025: -128.0%
FY 2016 5y median -45.9% FY 2025
ROIC -27.9%
FY 2016: 15.2%FY 2017: -44.1%FY 2018: -22.2%FY 2019: -27.2%FY 2020: -17.2%FY 2021: -6.7%FY 2022: -17.9%FY 2023: -33.2%FY 2024: -23.9%FY 2025: -27.9%
FY 2016 5y median -23.9% FY 2025
ROA -68.0%
FY 2016: 10.9%FY 2017: -137.0%FY 2018: -21.0%FY 2019: -26.9%FY 2020: -18.1%FY 2021: -11.0%FY 2022: -17.9%FY 2023: -34.1%FY 2024: -45.3%FY 2025: -68.0%
FY 2016 5y median -34.1% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 7.5%FY 2017: 38.8%FY 2018: 106.8%FY 2019: 100.8%FY 2020: 28.7%FY 2021: 27.4%FY 2022: 8.1%FY 2023: 6.7%FY 2024: 18.6%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 11.4%
FY 2016: 752.0%FY 2017: -671.2%FY 2018: -227.8%FY 2019: -43.6%FY 2020: 37.2%FY 2021: -2.0%FY 2022: -270.0%FY 2023: -65.7%FY 2024: 46.3%FY 2025: 11.4%
FY 2016 FY 2025
EPS (diluted) 14.2%
FY 2016: 190.9%FY 2017: -1460.0%FY 2018: 58.1%FY 2019: -7.0%FY 2020: 41.0%FY 2021: -25.0%FY 2022: -88.9%FY 2023: -25.9%FY 2024: 0.9%FY 2025: 14.2%
FY 2016 FY 2025
Free Cash Flow -27.8%
FY 2016: 572.5%FY 2017: -569.8%FY 2018: -200.4%FY 2019: -2.4%FY 2020: 48.9%FY 2021: -3.1%FY 2022: -451.5%FY 2023: -90.8%FY 2024: 73.5%FY 2025: -27.8%
FY 2016 FY 2025

Financial Health

Current Ratio 2.1×
FY 2016: 3.2×FY 2017: 3.9×FY 2018: 1.1×FY 2019: 1.4×FY 2020: 1.0×FY 2021: 8.0×FY 2022: 4.0×FY 2023: 2.8×FY 2024: 1.4×FY 2025: 2.1×
FY 2016 5y median 2.8× FY 2025
Quick Ratio 1.8×
FY 2016: 3.2×FY 2017: 3.9×FY 2018: 1.0×FY 2019: 1.1×FY 2020: 0.9×FY 2021: 7.8×FY 2022: 3.9×FY 2023: 2.5×FY 2024: 1.2×FY 2025: 1.8×
FY 2016 5y median 2.5× FY 2025
Debt / Equity 0.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.3×FY 2019: 0.2×FY 2020: 0.3×FY 2021: 0.1×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.4×FY 2025: 0.6×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -0.1×
FY 2016: -1.2×FY 2017: 0.5×FY 2018: -0.5×FY 2019: 0.6×FY 2020: -4.2×FY 2021: 27.0×FY 2022: 2.3×FY 2023: 0.0×FY 2024: -0.4×FY 2025: -0.1×
FY 2016 5y median 0.0× FY 2025
Interest Coverage -41.6×
FY 2016: 26.1×FY 2017: -85.5×FY 2018: -17.8×FY 2019: -4.9×FY 2020: -2.9×FY 2021: -4.8×FY 2022: -182×FY 2023: -854×FY 2024: -724×FY 2025: -41.6×
FY 2016 5y median -182× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.6%FY 2017: 0.4%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 43.0%FY 2017: -1.7%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-04-30